HLA-A*0201-restricted CD8+ T-cell epitopes identified in dengue viruses

Virology Journal

Volumn 9, Issue , 2012, Pages

  Duan, Zhi Liang ^a,b   Li, Qiang ^a,c   Wang, Zhi Bin ^a   Xia, Ke Dong ^a   Guo, Jiang Long ^a   Liu, Wen Quan ^a   Wen, Jin Sheng ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c THE THIRD AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CD8+ T cell epitope; Dengue virus; Immunogenicity

Indexed keywords

BINDING PROTEIN; EPITOPE; HLA A ANTIGEN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; PROTEIN VARIANT; VIRUS PROTEIN; HLA A*02:01 ANTIGEN; HLA A2 ANTIGEN; HLA-A*02:01 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; SEROTYPE; TRANSGENIC MOUSE; VIRUS CELL INTERACTION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; CLASSIFICATION; DENGUE VIRUS; GENETICS; IMMUNOLOGY; METABOLISM;

DENGUE VIRUS; DENGUE VIRUS GROUP; MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CROSS REACTIONS; DENGUE VIRUS; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A2 ANTIGEN; MICE; MICE, TRANSGENIC; VIRAL NONSTRUCTURAL PROTEINS;

MLCS; MLOWN;

EID: 84868227773     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-259     Document Type: Article

References (27)

1. Prospects for a dengue virus vaccine. Whitehead SS, Blaney JE, Durbin AP, Murphy BR, Nat Rev Microbiol 2007 5 7 518 528 10.1038/nrmicro1690 17558424 (Pubitemid 46925380)
2. Human IgG Fc receptor II mediumtes antibody-dependent enhancement of dengue virus infection. Littaua R, Kurane I, Ennis FA, J Immunol 1990 144 8 3183 3186 2139079 (Pubitemid 20149498)
3. Neutralization and antibody dependent enhancement of dengue viruses. Halstead SB, Adv Virus Res 2003 60 421 467 14689700 (Pubitemid 137639381)
4. Cross-reacting antibodies enhance dengue virus infection in humans. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G, Science 2010 328 5979 745 748 10.1126/science.1185181 20448183
5. Research on dengue during World War II. Sabin AB, AmJTrop Med Hyg 1952 1 1 30 50
6. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E, J Virol 2000 74 11 4957 4966 10.1128/JVI.74.11.4957-4966.2000 10799569 (Pubitemid 30313834)
7. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Diamond MS, Harris E, Virology 2001 289 2 297 311 10.1006/viro.2001.1114 11689052 (Pubitemid 33141009)
8. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G, Nat Med 2003 9 7 921 927 10.1038/nm887 12808447 (Pubitemid 36889936)
9. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. Imrie A, Meeks J, Gurary A, Sukhbataar M, Kitsutani P, Effler P, Zhao Z, J Virol 2007 81 18 10081 10091 10.1128/JVI.00330-07 17626101 (Pubitemid 350067712)
10. A protective role for dengue virus-specific CD8+ T cells. Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, Prestwood TR, Sette A, Shresta S, J Immunol 2009 182 8 4865 4873 10.4049/jimmunol.0801974 19342665
11. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL, J Immunol 2002 168 11 5959 5965 12023403 (Pubitemid 34556187)
12. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. Bashyam HS, Green S, Rothman AL, J Immunol 2006 176 5 2817 2824 16493038
13. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G, J Immunol 2006 176 6 3821 3829 16517753 (Pubitemid 43364031)
14. High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. Dong T, Moran E, Vinh Chau N, Simmons C, Luhn K, Peng Y, Wills B, Phuong Dung N, Thi Thu Thao L, Hien TT, McMichael A, Farrar J, Rowland-Jones S, PLoS One 2007 2 12 1192 10.1371/journal.pone.0001192 18060049 (Pubitemid 351663849)
15. Memory CD8+ T cells from naturally-acquired primary dengue virus infection are highly cross-reactive. Friberg H, Burns L, Woda M, Kalayanarooj S, Endy TP, Stephens HA, Green S, Rothman AL, Mathew A, Immunol Cell Biol 2011 89 1 122 129 10.1038/icb.2010.61 20421879
16. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Mathew A, Rothman AL, Immunol Rev 2008 225 300 313 10.1111/j.1600-065X.2008.00678.x 18837790
17. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. Simmons CP, Dong T, Chau NV, Dung NT, Chau TN, le Thao TT, Hien TT, Rowland-Jones S, Farrar J, J Virol 2005 79 9 5665 5675 10.1128/JVI.79.9.5665-5675.2005 15827181 (Pubitemid 40548235)
18. Dengue specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. An J, Zhou DS, Zhang JL, Morida H, Wang JL, Yasui K, Immunol Lett 2004 95 2 167 174 10.1016/j.imlet.2004.07.006 15388257 (Pubitemid 39237662)
19. Dengue vaccine-current progress and challenges. Swaminathan S, Khanna N, Curr Sci 2010 98 369 378
20. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. Zivny J, DeFronzo M, Jarry W, Jameson J, Cruz J, Ennis FA, Rothman AL, J Immunol 1999 163 5 2754 2760 10453018 (Pubitemid 29399202)
21. Identification of a dengue virus-specific HLA-A*0201-restricted CD8+ T cell epitope. Wen J, Duan Z, Jiang L, J Med Virol 2010 82 4 642 648 10.1002/jmv.21736 20166182
22. Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength. Lund O, Nascimento EJ, Maciel M Jr, Nielsen M, Larsen MV, Lundegaard C, Harndahl M, Lamberth K, Buus S, Salmon J, August TJ, Marques ET Jr, PLoS One 2011 6 10 26494 10.1371/journal.pone.0026494 22039500
23. Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, Sidney J, Kolla RV, De Silva AD, de Silva AM, Grey H, Peters B, Shresta S, Sette A, J Immunol 2011 187 8 4268 4279 10.4049/jimmunol.1101970 21918184
24. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. Chentoufi AA, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen A, Wu M, Zhu X, Mohebbi A, Buus S, Wechsler SL, Nesburn AB, BenMohamed L, J Immunol 2008 180 1 426 437 18097044
25. Identification of HLA-A3 and-B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A, J Immunol 1999 162 1156 1164 9916747 (Pubitemid 29035448)
26. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A, PLoS One 2009 4 10 7251 10.1371/journal.pone.0007251 19802382
27. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes. Gao G, Wang Q, Dai Z, Calcedo R, Sun X, Li G, Wilson JM, Hum Gene Ther 2008 19 9 927 936 10.1089/hum.2008.011 18788905